Drug-abusing patients - Can I refuse to treat them? by Naidoo, Sudeshni
Current Allergy & Clinical Immunology 2013 November Vol 26 No.4
228
ethics
DRUG-ABUSING PATIENTS  – CAN I REFUSE TO TREAT THEM?
CASE SCENARIO* 
In the past few months, there have been increasing 
numbers of drug-abusing patients attending my practice. 
More recently, an anorexic, very agitated and nervous 
20-year-old presented at my consulting rooms requesting 
medication for pain. He reported using methamphetamine 
(‘tik’) for the better part of 5 years. When he was refused 
pain medication he became aggressive and violent towards 
staff members. What are my ethical obligations, and can I 
refuse to treat patients who abuse drugs?
COMMENTARY
Drug abuse in South Africa is a growing and serious public-
health problem, and surveys show both an increase in the 
total number of users and, more alarmingly, a decrease 
in their average age.1-2 The illegal substance list includes 
marijuana, LSD, cocaine, heroin, crack, crystal meth, 
ecstasy, cat, khat, tik and mandrax. Many of these drugs are 
powerfully addictive and potent central nervous stimulants 
that cause not only behavioural (violent, aggressive, self-
injurious and paranoid behaviour during drug use, loss 
of interest in personal hygiene),3 but physiological (fatal 
kidney and lung disorders, hyperthermia, stroke and 
cardiac arrest)3 and psychological effects (leading to severe 
depression and suicidal tendencies during withdrawal, and 
permanent psychological problems resembling paranoid 
schizophrenia)3 (Table I).
Methamphetamine is a highly addictive psychostimulant 
that has been associated with serious health conditions 
such as premature labour, birth defects, memory loss, 
aggression, psychotic behaviours and potential heart 
and brain damage. It also contributes to sexual risk 
behaviour and increased transmission of HIV.2 In addition, 
the oral manifestations of drug abuse (poor oral health, 
xerostomia) and adverse effects on the hard tissues of the 
teeth (resulting in ‘meth mouth’) can be debilitating. Tik 
addiction has far-reaching consequences and a devastating 
impact not only on the long-term health of the abuser, but 
also on public medical, health and social services, where 
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increased nursing and security staff may be required. 
Patients who are addicted to drugs or are being treated 
for drug addiction are often complex to manage when they 
attend for medical care. Many factors need to be taken 
into consideration with regard to their treatment planning 
and clinical management. Practitioners should be aware of 
these factors in order to manage these patients ethically 
and effectively. Drug users are often portrayed negatively 
by their attitudes, behaviours and appearance, but fall 
into the group of vulnerable patients for many reasons 
including psychiatric and cognitive disorders that may limit 
their decision-making capacity. The principle of autonomy 
refers to the right of an individual to make decisions for 
him/herself regarding his/her treatment, after being given 
all the necessary and relevant information.  However, this 
principle is used for persons who have the capacity to 
make their own decisions and becomes problematic for 
those who lack capacity. Respect for autonomy creates 
the following obligations – that of informed consent, 
confidentiality, truth-telling and effective communication. 
Many questions have been raised regarding the extent to 
which drug users possess the mental competence to make 
voluntary uncoerced treatment choices.4-6 For informed 
consent to be valid, comprehension and voluntariness are 
required.7
Beneficence refers to doing good, and all healthcare workers 
have the responsibility to provide beneficial treatment, to 
benefit patients by not inflicting harm, by preventing and 
removing harm. The rules of beneficence are to protect 
and defend the rights of others, prevent harm, remove 
conditions that will cause harm to others, help persons with 
disabilities and to rescue persons in danger.7 Whenever 
we try to help others, we inevitably risk harming them.8 
In the practice of medicine it is essential to balance these 
principles to achieve net benefit for the patient. 
Confidentiality is a way of respecting the patient’s autonomy 
and is an especially sensitive matter with regard to substance 
use in adolescent populations.9 Furthermore, maintaining 
confidentiality of participants’ personal information is 
critical as breach of confidentiality could result in harm 
and criminal prosecution.10 In some circumstances it may 
not be easy to decide what constitutes harm and what 
constitutes a benefit, but practitioners must have the best 
interest of the patient in mind at all times.  
Justice as a principle refers to fairness and in terms of 
health care refers to the fair treatment of patients. From 
a legal point of view fairness to patients is an obligation 
of the principle of justice. A right may be regarded as an 
entitlement to something that is considered valuable. In the 
context of the doctor-patient relationship, the patient has 
certain rights, like the right to privacy and confidentiality 
from the doctor.  On the other hand, the patient has an 
obligation to follow the healthcare worker’s advice in 
terms of adhering to prescribed treatments.11 Whether 
or not drug use is recognised as a basic right, individuals 
living with an addiction are among the most stigmatised 
members of society. Individuals who are addicted to drugs 
fall into the vulnerable patient category, but denying or 
hindering treatment access to them in the name of justice 
and protection may ironically create an injustice and harm 
individuals because treatment may be beneficial them.12 
While there may be mitigating circumstances related to 
treatment safety or drug interactions, reasons for excluding 
them from treatment and care is unethical.13
Furthermore, once the practitioner recognises the 
symptoms and signs of drug abuse, the patient should be 
referred to a physician or substance abuse rehabilitation 
centre (www.sancanational.org.za). Restoring the dental 
appearance of patients recovered from drug abuse may 
help them regain self-esteem. Establishing a good rapport 
and bond of trust will encourage this group of patients 
to return and obtain often much-needed care.14 There 
are many ethical issues related to the management of 
vulnerable patients who abuse drugs and the ethical 
principles of autonomy, beneficence, non-maleficence 
and justice become even more important to uphold. 
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